Viveve Medical Inc expected to post a loss of 51  cents a share - Earnings Preview

Viveve Medical

12/05/2021 24:05

* Viveve Medical Inc  VIVE.OQ   VIVE.O  is expected to show a
rise in quarterly revenue when it reports results on May 13 .
* The Englewood, Colorado-based company is expected to report 
 a 2.0% increase in revenue to $1.33 million from $1.3 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Viveve Medical Inc is
for a loss of 51 cents per share. For the same quarter last
year, the company reported a loss of $8.20 per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts had risen by about 2.1%
in the last three months. ​
* Wall Street's median 12-month price target for Viveve Medical
Inc is $9.63​, about 72.6% above​ its last closing price
of $2.64. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -2.69       -2.59      -1.85     Beat    28.7
 Sep. 30 2020              -5.30      -2.60     Beat    50.9
 Jun. 30 2020  -5.90       -5.90      -4.40     Beat    25.4​
 Mar. 31 2020  -126.00     -126.00    -8.20     Beat    93.5
 Dec.          ​           -12.40     -43.77    Missed  -253​
 31​ 2019​                                              
 Sep. 30 2019  -160.00     -160.00    -135.10   Beat    15.6​
 Jun. 30 2019  -173.72     -178.33    -210.00   Missed  -17.8
 Mar. 31 2019  -294.17     -264.44    -220.00   Beat    16.8
 This summary was machine generated May 11 at 23:05 GMT.  All
figures in US dollars unless otherwise stated